Publications

Title

Author

Year

Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.

Tanner, R; Kakalacheva, K; Miller, E; Pathan, AA; Chalk, R; Sander, CR; Scriba, T; Tameris, M; Hawkridge, T; Mahomed, H; Hussey, G; Hanekom, W; Checkley, A; McShane, H; FLETCHER, HA;

2014

BMC infectious diseases, (2014).14 1 10.1186/s12879-014-0660-7.

Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting.

Perdigão, J; Silva, H; Machado, D; Macedo, R; Maltez, F; Silva, C; Jordao, L; Couto, I; Mallard, K; COLL, F; Hill-Cawthorne, GA; MCNERNEY, R; Pain, A; CLARK, TG; Viveiros, M; Portugal, I;

2014

BMC genomics, (2014).15 1 10.1186/1471-2164-15-991.

The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.

Odone, A; Amadasi, S; WHITE, RG; Cohen, T; GRANT, AD; HOUBEN, RM G J;

2014

PloS one, (2014).9 11 10.1371/journal.pone.0112017.

Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality.

Pretorius, C; Glaziou, P; Dodd, PJ; WHITE, R; HOUBEN, R;

2014

AIDS (London, England), (2014).28 Sup 4 10.1097/QAD.0000000000000484.

Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.

Zwerling, A; WHITE, RG; VASSALL, A; Cohen, T; Dowdy, DW; HOUBEN, RM G J;

2014

PloS one, (2014).9 10 10.1371/journal.pone.0110558.

Symptom reporting among prevalent tuberculosis cases who smoke, are HIV-positive or have hyperglycaemia.

Sattar, S; Van Schalkwyk, C; Claassens, M; Dunbar, R; FLOYD, S; Enarson, DA; GODFREY-FAUSSETT, P; AYLES, H; Beyers, N;

2014

Public health action, (2014).4 4 10.5588/pha.14.0081.

A cluster randomised trial to evaluate the effect of optimising TB/HIV integration on patient level outcomes: the "merge" trial protocol.

Kufa, T; Hippner, P; Charalambous, S; KIELMANN, K; VASSALL, A; CHURCHYARD, GJ; GRANT, AD; FIELDING, KL;

2014

Contemporary clinical trials, (2014).39 2 10.1016/j.cct.2014.10.003.

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.

KNIGHT, GM; GRIFFITHS, UK; SUMNER, T; LAURENCE, YV; GHEORGHE, A; VASSALL, A; Glaziou, P; WHITE, RG;

2014

Proceedings of the National Academy of Sciences of the United States of America, (2014).111 43 10.1073/pnas.1404386111.

Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines.

Keller-Stanislawski, B; Englund, JA; Kang, G; MANGTANI, P; Neuzil, K; Nohynek, H; Pless, R; Lambach, P; Zuber, P;

2014

Vaccine, (2014).32 52 10.1016/j.vaccine.2014.09.052.

Africa--not lost but still sick. Implementing interventions to prevent HIV-associated tuberculosis.

LAWN, SD;

2014

The international journal of tuberculosis and lung disease, (2014).18 10 10.5588/ijtld.14.0583.